Canadian consensus algorithm for erectile rehabilitation following prostate cancer treatment

Dean S. Elterman, Anika R. Petrella, Lauren M. Walker et al

Can Urol Assoc J. 2019 Aug; 13(8): 239–24

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737730/

 

Geographical variations in prostate cancer outcomes: a systematic review of international evidence

Paramita Dasgupta, Peter D. Baade, Joanne F. Aitken et al

Front Oncol. 2019; 9: 238.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463763/

 

A review of optimal prostate biopsy: indication and techniques

Justin Streicher, Brian Lee Meyerson, Vidhya Karivedu, Abhinav Sidana

Ther Adv Urol. 2019 Jan-Dec; 11: 1756287219870074

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713958/

 

Treatment of advanced prostate cancer: Where are we in 2019?

F S M Monteiro, A Soares, F N G de Oliveira et al

Brazilian Journal of Oncology 2019, vol 15

http://brazilianjournalofoncology.com.br/details/60/en-US/treatment-of-advanced-prostate-cancer–where-are-we-in-2019

 

Prostate cancer ¨super-active surveillance¨ era opened by vascular targeted photodynamic therapy

Renato B Corradi, Thiago C Travassos, Leonardo O Reis

Res Rep Urol. 2019; 11: 157–163

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549684/

 

Revisiting current treatment options for stress urinary incontinence and pelvic organ prolapse: a contemporary literature review

You (Maria) Wu, Blayne Welk

Res Rep Urol 2019: vol 11: 179-188

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590839/

 

Magnetic resonance imaging-transtrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer

Sunao Shoji

Investig Clin Urol. 2019 Jan; 60(1): 4–13

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318202/

 

How accurately can prostate gland imaging measure the prostate gland volume? Results of a systematic review

David R. H. Christie, Christopher F. Sharpley

Prostate Cancer. 2019; 2019: 6932572

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420971/

 

Glycans as biomarkers in prostate cancer

Emma Scott, Jennifer Munkley

Int J Mol Sci. 2019 Mar; 20(6): 1389

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470778/

 

Lower urinary tract symptoms and prostate cancer: is PSA testing in men with symptoms wise?

J Just, F Osgun, C Knight

British Journal of General Practice 2018, vol 68 (679): 541-542

https://bjgp.org/content/68/676/541

 

Local treatment of metastatic prostate cancer: What is the evidence so far?

P L Almeida, B J Pereira

Prostate Cancer 2018, Article ID 2654572, 7 pages

https://www.hindawi.com/journals/pc/2018/2654572/

 

Localized prostate cancer: treatment options

S Brawley, R Mohan, c D Nein

Am Fam Physician 2018, vol 97 (12): 798-805

https://www.aafp.org/afp/2018/0615/p798.html

 

Recent advances in prostate cancer treatment and drug discovery

Ekaterina Nevedomskaya, Simon J. Baumgart, Bernard Haendler

Int J Mol Sci. 2018 May; 19(5): 1359

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983695/

 

Localized prostate cancer: treatment options

S Braweley, R Mohan, C D Nein

Am Fam Physician jun 2018

https://www.aafp.org/afp/2018/0615/p798.html

 

Screening for prostate cancer

R Wolff, Y J Jadotte

Am Fam Physician 2018, vol 98 (8): 537-538

https://www.aafp.org/afp/2018/1015/od1.html

 

Circulating blood miRNAs for prostate risk stratification: mirroring the underlying tumor biology with liquid biopsies

Christianne Hoey, Stanley K Liu

Res Rep Urol. 2019; 11: 29–42

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398395/

 

Clinical Preventive Service Recommendation: Prostate Cancer – PSA-Based Prostate Cancer Scrreing in Men 55-59

https://www.aafp.org/patient-care/clinical-recommendations/all/prostate-cancer.html

 

Current surgical techniques os enucleation I homium laser encucleation of the prostate

Seung-June Oh

Investig Clin Urol. 2019 Sep; 60(5): 333–342

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722407/

 

Role of androgen receptor in prostate cancer: a review

Kazutoshi Fujita, Norio Nonomura

World J Mens Health. 2019 Sep; 37(3): 288–295

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704300/

 

Profiling prostate cancer therapeutic resistance

Cameron A. Wade, Natasha Kyprianou

Int J Mol Sci. 2018 Mar; 19(3): 904.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877765/

 

Primary cryotherapy for localized or locally advanced prostate cancer

Jae Hung Jung, Michael C Risk, Robert Goldfarb, et al

Cochrane Database Syst Rev. 2018 May; 2018(5): CD005010

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494517/

 

Is there an optimal curative option in HIV-positive men with localized prostate cancer? A systematic review

John Baladakis, Marlon Perera, Damien Bolton, Nathan Lawrentschuk, Ahmed Adam

Curr Urol. 2019 Jul; 12(4): 169–176

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738179/

 

Prostate-specific antigen (PSA) and distress: – a cross-sectional nationwide survey in men with prostate cancer in Sweden

Ulrika Rönningås, Per Fransson, Maja Holm, Agneta Wennman-Larsen

BMC Urol. 2019; 19: 66.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626380/

 

Reduced risk of prostate cancer with 5alpha-reductase inhibitors

Ian Thompson, Jr., Phyllis Goodman, Catherine Tangen

J Natl Cancer Inst. 2018 Nov; 110(11): 1159–1160

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454440/

 

Radiotherapy for prostate cancer: DISCERN quality assessment of patient-oriented websites in 2018

  1. Janssen, F. B. Fahlbusch, L. Käsmann, D. Rades, D. Vordermark

BMC Urol. 2019; 19: 42

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537434/

 

Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers

Anika Kremer, Tobias Kremer, Glen Kristiansen, Yuri Tolkach

BMC Urol. 2019; 19: 46.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554887/

 

Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010-2015

B A Mahal, S Butler, I Franco et al

JAMA 2019, vol 321 (7): 704-706

https://jamanetwork.com/journals/jama/fullarticle/2724897

 

Identifying quality of life indicators to improve outpatient pharmacy services for prostate cancer patients: a comparison between brazilian and british experiences

H Patel, P M Aguiar, A Pessoa Jr et al

Int braz j urol 2019, vol 45 (3)

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000300435&lng=en&nrm=iso&tlng=en

 

Second brazilian consensus on the treatment of advanced prostate cancer: a SBOC-SBU-SBRT panel Int A D Sasse, R B dos Reis, L M Nogueira et al

Int braz j urol 2019, vol 45 (3)

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000300449

 

Physical activity in relation to risk of prostate cancer: a systematic review and meta-analysis

I N Benke, M F Leitzmann, G Behrens, D Schmid

Annals of Oncology 2018, vol 29 (5): 1154-1179

https://academic.oup.com/annonc/article/29/5/1154/4904101

 

PSA and beyond: alternative prostate cancer biomarkers

Sharanjot Saini

Cell Oncol (Dordr). 2016 Apr; 39(2): 97–106

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821699/

 

National implementation on multi-parametric magnetic resonance imaging for prostate cancer detection – recommendations form a UK consensus meeting

Mrishta Brizmohun Appayya, Jim Adshead, Hashim U. Ahmed et al

BJU Int. 2018 Jul; 122(1): 13–25

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334741/

 

The association between vasectomy and prostate cancer: a systematic review and meta-analysis

Bimal Bhindi, Christopher J. D. Wallis, Madhur Nayan, et al

JAMA Intern Med. 2017 Sep; 177(9): 1273–1286

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710573/

 

The current evidence on statin use and prostate cancer prevention: are we there yet?

Mahmoud A. Alfaqih, Emma H. Allott, Robert J. Hamilton et al

Nat Rev Urol. 2017 Feb; 14(2): 107–119

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830185/

 

Use of androgen deprivation therapy with prostate brachytherapy, A systematic literature review

Mira Keyes, Gregory Merrick, Steven J. Frank et al

Brachytherapy. 2017 Mar-Apr; 16(2): 245–265

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075682/

 

Prostate cancer in gay, bisexual, and other men who have sex with men: a review

B.R. Simon Rosser, Enyinnaya Merengwa, Benjamin D. Capistrant et al

LGBT Health. 2016 Feb 1; 3(1): 32–41

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770844/

 

The very high risk prostate cancer – a contemporary update

Roy Mano, James Eastham, Ofer Yossepowitch

Prostate Cancer Prostatic Dis. 2016 Dec; 19(4): 340–348

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559730/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Data: out 2019